134 related articles for article (PubMed ID: 1660590)
1. Schistosoma mansoni: larval damage and role of effector cell(s) in the synergy between vaccine immunity and praziquantel treatment.
Piper KP; Mott RF; Hockley DJ; McLaren DJ
Parasitology; 1991 Oct; 103 Pt 2():207-24. PubMed ID: 1660590
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni: histological analysis of the synergistic interaction between vaccine immunity and praziquantel therapy in the lungs of mice.
Piper KP; Mott RF; McLaren DJ
Parasite Immunol; 1990 Jul; 12(4):367-87. PubMed ID: 2119493
[TBL] [Abstract][Full Text] [Related]
3. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni: enhanced efficacy of praziquantel treatment in immune mice.
Flisser A; Delgado VS; McLaren DJ
Parasite Immunol; 1989 Jul; 11(4):319-28. PubMed ID: 2506506
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma mansoni: evidence that eosinophils and/or macrophages contribute to skin-phase challenge attrition in vaccinated CBA/Ca mice.
Ward RE; McLaren DJ
Parasitology; 1988 Feb; 96 ( Pt 1)():63-84. PubMed ID: 3129691
[TBL] [Abstract][Full Text] [Related]
6. Schistosoma japonicum and S. mansoni: ultrastructural damage in the tegument and reproductive organs after treatment with levo- and dextro-praziquantel.
Irie Y; Utsunomiya H; Tanaka M; Ohmae H; Nara T; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):204-11. PubMed ID: 2505625
[TBL] [Abstract][Full Text] [Related]
7. Transmission electron microscopic observations on ultrastructural alterations in Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel in addition to passive immunization with normal and vaccinated rabbit sera against infection.
El-Shabasy EA; Reda ES; Abdeen SH; Said AE; Ouhtit A
Parasitol Res; 2015 Apr; 114(4):1563-80. PubMed ID: 25786393
[TBL] [Abstract][Full Text] [Related]
8. Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel.
Shaw MK
Parasitology; 1990 Feb; 100 Pt 1():65-72. PubMed ID: 2107508
[TBL] [Abstract][Full Text] [Related]
9. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
10. Experimental animal models in vaccination against schistosomiasis.
McLaren DJ
Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():188-96. PubMed ID: 2517864
[TBL] [Abstract][Full Text] [Related]
11. Evidence that radio-sensitive cells are central to skin-phase protective immunity in CBA/Ca mice vaccinated with radiation-attenuated cercariae of Schistosoma mansoni as well as in naive mice protected with vaccine serum.
Delgado VS; McLaren DJ
Parasitology; 1990 Feb; 100 Pt 1():45-56. PubMed ID: 2156212
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel.
Shaw MK; Erasmus DA
Parasitology; 1987 Apr; 94 ( Pt 2)():243-54. PubMed ID: 3108831
[TBL] [Abstract][Full Text] [Related]
14. Effect of praziquantel treatment on lung-stage larvae of Schistosoma mansoni in vivo.
Flisser A; McLaren DJ
Parasitology; 1989 Apr; 98 Pt 2():203-11. PubMed ID: 2474788
[TBL] [Abstract][Full Text] [Related]
15. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
Brindley PJ; Strand M; Norden AP; Sher A
Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
[TBL] [Abstract][Full Text] [Related]
16. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
Fallon PG; Doenhoff MJ
Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
[TBL] [Abstract][Full Text] [Related]
17. Effect of praziquantel on the migration and survival of developmental stages of Schistosoma mansoni in mice.
Flisser A; Elsaghier AA; McLaren DJ
Int J Parasitol; 1989 Sep; 19(6):665-72. PubMed ID: 2509390
[TBL] [Abstract][Full Text] [Related]
18. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni: influence of immunization and challenge schedules on the sites and mechanisms of resistance in CBA/Ca mice vaccinated with highly irradiated cercariae.
Elsaghier AA; McLaren DJ
J Helminthol; 1989 Sep; 63(3):173-90. PubMed ID: 2507627
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
Fallon PG; Hamilton JV; Doenhoff MJ
Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
